Delivery Order SPE2D020D0014-SPE2D326F3171
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to Pfizer Inc. on January 5, 2026, for the supply of Depo-Medrol 200 mg/5 mL vials. This firm fixed price delivery order, valued at $1,949.22, represents a continuation of Pfizer's role as a critical pharmaceutical supplier to federal healthcare programs. The contract does not utilize small business set-aside provisions and is scheduled for completion by January 6, 2026, with fulfillment occurring at Pfizer's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $1,949.22 firm fixed-price delivery order to Pfizer Inc. on January 5, 2026, for the supply of Depo-Medrol 200 mg/5 mL vials. This delivery order, which will be completed by January 6, 2026, represents a routine pharmaceutical procurement through the Medical Supply Chain, a component of Defense Logistics Agency Troop Support that manages critical medical supplies for federal healthcare organizations. No small business set-aside...
- Pfizer Inc. was awarded a delivery order valued at $1,362.06 by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, for the supply of Solu-Medrol 500 mg vials. This firm fixed-price contract was executed on July 28, 2025, with an ultimate completion date of July 29, 2025, and was performed in New York, New York. No small business set-aside designation was utilized for this award, reflecting Pfizer's status as an established large pharmaceutical manufacturer....
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at one hundred thirty-two thousand four hundred forty dollars to Pfizer Inc., doing business as Pfizer, for two thousand milligrams vials of Solu-Medrol. Place of performance will be Pfizer's New York City location. The order is to be completed between July 6th and July 11th, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency Troop Support...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at one hundred thirty-two thousand four hundred forty dollars to Pfizer Inc. for two thousand milligrams of Solu-Medrol vials. Pfizer will deliver the requested pharmaceutical products to a location in New York City by July 11, 2023, fulfilling the agency's requirement under this contract issued on July 6, 2023. As a major provider of medical supplies and logistics support to the U.S. Department...
- The Defense Logistics Agency Troop Support Medical awarded Pfizer Inc., doing business as Pfizer, a $66,200 firm fixed price delivery order to supply 2,000 vials of SOLU-MEDROL (methylprednisolone sodium succinate) for injection. Pfizer will deliver the pharmaceutical products from its New York City location to support DLA Troop Support Medical programs. No major subcontractors or set aside designations were indicated. This delivery order was issued against an existing DLA pharmaceutical...
- The Defense Logistics Agency Troop Support Medical awarded a $132,400 firm fixed price delivery order to Pfizer Inc., doing business as Pfizer, for 2,000 vials of SOLU-MEDROL (methylprednisolone sodium succinate) injectable medication. The place of performance is Pfizer's New York City location. The delivery order period of performance is July 6-11, 2023. DLA Troop Support Medical supports the Department of Defense by procuring pharmaceuticals and other medical supplies. This delivery order...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Pfizer Inc., a global pharmaceutical corporation headquartered in New York. The $443,481.61 delivery order contract is for firm fixed-price medical supplies and pharmaceuticals, including controlled substances, injectable medications, and critical medical products. The contract has no small business set-aside designation, reflecting Pfizer's status as a large, established...
- The Defense Logistics Agency Troop Support Medical awarded a $194,100 delivery order contract to Pfizer Inc. for the supply of 500 mg methylprednisolone sodium succinate injections. As the prime contractor, Pfizer will deliver the injectable corticosteroid drug to an address in New York City between August 7-10, 2023. The firm fixed price contract was awarded under the Medical Prime Vendor program, a strategic sourcing initiative managed by DLA Troop Support to provide medical supplies to the...
- This is a $924,719.33 firm-fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. The contract will run through September 30, 2025 and provides for the supply of various pharmaceuticals and medical products, including controlled substances, antibiotics, and vaccines. Pfizer, a global pharmaceutical corporation, serves as the prime contractor on this award. The contract is not set-aside and Pfizer has been awarded several significant Indefinite...
- SPE2D020D0014Indefinite Delivery Contract
- SPE2D020D0014-SPE2D326F3171Delivery Order
The U.S. Department of Defense's Medical Supply Chain awarded Pfizer Inc. a delivery order valued at $1,949.22 for Depo-Medrol 200 mg/5 ml vials on January 5, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 6, 2026, represents a continuation of Pfizer's role as a critical supplier of injectable pharmaceutical products to federal healthcare agencies. The award was made without small business set-aside designation, consistent with Pfizer's status as an established large pharmaceutical manufacturer. Performance will occur in New York, New York. This delivery order exemplifies Pfizer's ongoing participation in the Defense Logistics Agency Troop Support's Medical Supply Chain program, through which the company supplies essential medications across multiple therapeutic categories to federal agencies including the Department of Defense, Department of Veterans Affairs, and other government healthcare organizations. Pfizer's substantial presence in federal pharmaceutical procurement is further reinforced by its two major Indefinite Delivery Vehicles totaling over $120 million, which establish the company's strategic importance in supplying critical medical interventions across federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 1/4/26 |